Hepatic lipase (LIPC) promoter polymorphism in men with coronary artery disease: Allele frequency and effects on hepatic lipase activity and plasma HDL-C concentrations

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 8, 1999, Pages 1975-1978

  Shohet, Ralph V ^b   Vega, Gloria L ^a   Anwar, Azam ^a   Cigarroa, Joaquin E ^b   Grundy, Scott M ^a,b   Cohen, Jonathan C ^a,b,c  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Atherosclerosis; HDL; Hepatic lipase; Polymorphism; Risk factor

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIVER TRIACYLGLYCEROL LIPASE;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DNA POLYMORPHISM; GENE FREQUENCY; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION;

EID: 0032810064     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.8.1975     Document Type: Article

References (25)

1. National Cholesterol Education Program. Second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults NIH Publication No.93-3095. 1993.
2. Krauss RM. Dense low density lipoproteins and coronary artery disease. Am J Cardiol. 1995;75:53B-57B.
3. Gray RS, Robbins DC, Wang W, Yeh JL, Fabsitz RR, Cowan LD, Welty TK, Lee ET, Krauss RM, Howard BV. Relation of LDL size to the insulin resistance syndrome and coronary heart disease in American Indians: the Strone Heart Study. Arterioscler Thromb Biol. 1997;17:2713-2720.
4. Superko HR. What can we learn about dense low density lipoprotein and lipoprotein particles from clinical trials? Curr Opin Lipidol. 1996;7: 363-368.
5. Kuusi T, Saarinen P, Nikkila EA. Evidence for the role of hepatic endothelial lipase in the metabolism of plasma high density lipoprotein2 in man. Atherosclerosis. 1980;36:589-593.
6. Blades B, Vega GL, Grundy SM. Activities of lipoprotein lipase and hepatic triglyceride lipase in postheparin plasma of patients with low concentrations of HDL cholesterol. Arterioscler Thromb. 1993;13: 1227-1235.
7. Cohen JC, Wang Z, Grundy SM, Stoesz MR, Guerra R. Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels. J Clin Invest. 1994;94:2377-2384.
8. Campos H, Dreon DM, Krauss RM. Associations of hepatic and lipoprotein lipase activities with changes in dietary composition and low density lipoprotein subclasses. J Lipid Res. 1995;36:462-472.
9. Zambon A, Austin MA, Brown BG, Hokanson JE, Brunzell JD. Effect of hepatic lipase on LDL in normal men and those with coronary artery disease. Arterioscler Thromb. 1993;13:147-153.
10. Tan KC, Cooper MB, Ling KL, Griffin BA, Freeman DJ, Packard CJ, Shepherd J, Hales CN, Betteridge DJ. Fasting and postprandial determinants for the occurrence of small dense LDL species in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia: the involvement of insulin, insulin precursor species and insulin resistance. Atherosclerosis. 1995;113:273-287.
11. Barth JD, Jansen H, Kromhout D, Reiber JH, Birkenhager JC, Arntzenius AC. Progression and regression of human coronary atherosclerosis: the role of lipoproteins, lipases and thyroid hormones in coronary lesion growth. Atherosclerosis. 1987;68:51-58.
12. Barth JD, Jansen H, Hugenholtz PG, Birkenhager JC. Post-heparin lipases, lipids and related hormones in men undergoing coronary arteriography to assess atherosclerosis. Atherosclerosis. 1983;48:235-251.
13. Barth JD, Jansen H, Kromhout D, Reiber J, Birkenhager JC, Arntzenius AC. Diet and the role of lipoproteins, lipases, and thyroid hormones in coronary lesion growth. J Cardiovasc Pharmacol 1987;9(suppl 10): S42-S46.
14. Groot PH, van Stiphout WA, Krauss XH, Jansen H, van Tol A, van Ramshorst E, Chin-On S, Hofman A, Cresswell SR, Havekes L. Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler Thromb. 1991;11:653-662.
15. Katzel LI, Coon PJ, Busby MJ, Gottlieb SO, Krauss RM, Goldberg AP. Reduced HDL2 cholesterol subspecies and elevated postheparin hepatic lipase activity in older men with abdominal obesity and asymptomatic myocardial ischemia. Arterioscler Thromb. 1992;12:814-823.
16. Baynes C, Henderson AD, Anyaoku V, Richmond W, Hughes CL, Johnston DG, Elkeles RS. The role of insulin insensitivity and hepatic lipase in the dyslipidaemia of type 2 diabetes. Diabet Med. 1991;8: 560-566.
17. Laakso M, Sarlund H, Ehnholm C, Voutilainen E, Aro A, Pyorala K. Relationship between postheparin plasma lipases and high-density lipoprotein cholesterol in different types of diabetes. Diabetologia. 1987; 30:703-706.
18. Tikkanen MJ, Nikkila EA. Regulation of hepatic lipase and serum lipoproteins by sex steroids. Am Heart J. 1987;113:562-567.
19. Cominacini L, Garbin U, Davoli A, Campagnola M, De Santis A, Pasini, Pastorino AM, Bosello O. High-density lipoprotein cholesterol concentrations and postheparin hepatic and lipoprotein lipases in obesity: relationships with plasma insulin levels. Ann Nutr Metab. 1993;37:175-184.
20. Nie L, Wang J, Clark LT, Tang A, Vega GL, Grundy SM, Cohen JC. Body mass index and hepatic lipase gene (LIPC) polymorphism jointly influence postheparin plasma hepatic lipase activity. J Lipid Res. 1998; 39:1127-1130.
21. Hegele RA, Little JA, Vezina A, Maguire GF, Tu L, Wolever TS, Jenkins DJ, Connelly PW. Hepatic lipase deficiency: clinical, biochemical, and molecular genetic characteristics. Arterioscler Thromb. 1993;13: 720-728.
22. Vega GL, Clark LT, Tang A, Marcovina S, Grundy SM, Cohen JC. Hepatic lipase activity is lower in African American than in white American men: effects of 5′ flanking polymorphism in the hepatic lipase gene. J Lipid Res. 1998;39:228-232.
23. Guerra R, Wang JP, Grundy SM, Cohen JC. A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol. Proc Natl Acad Sci U S A. 1997;94:4532-4537.
24. Jansen H, Verhoeven AM, Weeks L, Kastelein JP, Halley DJ, Vandenouweland A, Jukema JW, Seidell JC, Birkenhager JC. Common C-to-T substitution at position -480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery disease patients. Arterioscler Thromb Vasc Biol. 1997;17:2837-2842.
25. Murtomaki S, Tahvanainen E, Antikainen M, Tiret L, Nicaud V, Jansen H, Ehnholm C. Hepatic lipase gene polymorphisms influence plasma HDL levels. Results from Finnish EARS participants: European Atherosclerosis Research Study. Arterioscler Thromb Vasc Biol. 1997;17: 1879-1884.